Details for Patent: 9,872,865
Which drugs does patent 9,872,865 protect, and when does it expire?
Patent 9,872,865 protects RELYVRIO and is included in one NDA.
This patent has forty-two patent family members in nineteen countries.
Summary for Patent: 9,872,865
| Title: | Compositions for improving cell viability and methods of use thereof |
| Abstract: | This invention relates to methods and compositions for use improving cell viability, particularly neural cell viability, and more particularly to methods and compositions for use improving cell viability by reducing reactive oxygen metabolite-mediated oxidative damage in a cell, regulating redox homeostasis in a cell, or reducing mitochondrial dysfunction in a cell. The invention further relates to the administration of the bile acid tauroursodeoxycholic acid (TUDCA) in combination with phenylbutyric Acid (PBA) to improve cell viability, and treat at least one symptom associated with, prevent the time of onset of, or slow the development of a disease related to oxidative stress. |
| Inventor(s): | Joshua Cohen, Justin Klee |
| Assignee: | Amylyx Pharmaceuticals Inc |
| Application Number: | US14/140,083 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,872,865
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amylyx | RELYVRIO | sodium phenylbutyrate; taurursodiol | FOR SUSPENSION;ORAL | 216660-001 | Sep 29, 2022 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN ADULTS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,872,865
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014242123 | ⤷ Start Trial | |||
| Australia | 2019200658 | ⤷ Start Trial | |||
| Australia | 2021201770 | ⤷ Start Trial | |||
| Australia | 2022221410 | ⤷ Start Trial | |||
| Canada | 2908683 | ⤷ Start Trial | |||
| China | 105050593 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
